Giovannoni G, et al. Cladribine tablets in high disease activity (HDA) subgroups from the CLARITY study of patients with relapsing multiple sclerosis (RMS). EP1157. EAN 2017.
Orexinereceptor-2-agonist verbetert slaaplatentie bij narcolepsie type 1
okt 2023